Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aptinyx Inc (NQ: APTX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 18, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Aptinyx Inc

< Previous 1 2 Next >
Aptinyx Completes Enrollment in Phase 2b Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy
From Aptinyx Inc.
Via Business Wire
Aptinyx to Report Third Quarter 2021 Financial Results on Tuesday, November 9, 2021
From Aptinyx Inc.
Via Business Wire
Aptinyx Appoints Gilmore O’Neill, M.B., M.M.Sc., to Board of Directors
From Aptinyx Inc.
Via Business Wire
Aptinyx to Participate in 2021 Cantor Virtual Global Healthcare Conference
From Aptinyx Inc.
Via Business Wire
Aptinyx Secures $50 Million Growth Capital Credit Facility from K2 HealthVentures
From Aptinyx Inc.
Via Business Wire
Aptinyx to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
From Aptinyx Inc.
Via Business Wire
CORRECTING and REPLACING Aptinyx Reports Second Quarter 2021 Financial Results and Business Highlights
From Aptinyx Inc.
Via Business Wire
Aptinyx Reports Second Quarter 2021 Financial Results and Business Highlights
From Aptinyx Inc.
Via Business Wire
Aptinyx to Participate in 2021 Wedbush PacGrow Healthcare Virtual Conference
From Aptinyx Inc.
Via Business Wire
Aptinyx to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021
From Aptinyx Inc.
Via Business Wire
Aptinyx to Participate in William Blair Biotech Focus Conference 2021
From Aptinyx Inc.
Via Business Wire
Aptinyx to Participate in Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit
From Aptinyx Inc.
Via Business Wire
Aptinyx to Participate in Upcoming Investor Conferences
From Aptinyx Inc.
Via Business Wire
Aptinyx Provides Update on NYX-783 Development Program for the Treatment of Post-Traumatic Stress Disorder
From Aptinyx Inc.
Via Business Wire
Aptinyx Reports First Quarter 2021 Financial Results and Highlights
From Aptinyx Inc.
Via Business Wire
Aptinyx Appoints Joan W. Miller, M.D. to Board of Directors
From Aptinyx Inc.
Via Business Wire
Aptinyx to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
From Aptinyx Inc.
Via Business Wire
Aptinyx Presents Additional Positive Data from Phase 2 Exploratory Study of NYX-783 in PTSD at Society of Biological Psychiatry Annual Meeting
From Aptinyx Inc.
Via Business Wire
Aptinyx to Participate in Upcoming Conferences
From Aptinyx Inc.
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.